Literature DB >> 25060627

Attenuated psychosis syndrome: need for debate on a new disorder.

William T Carpenter1.   

Abstract

This 'pro' statement of the controversial issue, defending the need for a new disorder classification of attenuated psychosis syndrome (APS), provides data supporting the clinical validity of this category and responds to the most frequently asserted criticisms. It provides arguments why APS is not pathologizing non-ill behaviors and is not stigmatizing for those affected but rather they merit clinical attention for what is already manifest. It also argues against the view that establishing the diagnostic category of APS results in an unreasoned excessive use of antipsychotic medications but rather encourages prevention and early intervention programs. Finally, bodies of research are presented which could contribute to further validating APS and provide the preconditions for moving this category from Section 3 to Section 2 of DSM-5.1.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25060627     DOI: 10.1159/000365221

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  9 in total

1.  Age matters in the prevalence and clinical significance of ultra-high-risk for psychosis symptoms and criteria in the general population: Findings from the BEAR and BEARS-kid studies.

Authors:  Benno G Schimmelmann; Chantal Michel; Alexandra Martz-Irngartinger; Caroline Linder; Frauke Schultze-Lutter
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

2.  Early intervention: how early and with what?

Authors:  William T Carpenter; Robert W Buchanan
Journal:  Schizophr Bull       Date:  2014-11-14       Impact factor: 9.306

3.  Diagnostic Concepts in the Context of Clinical High Risk/Attenuated Psychosis Syndrome.

Authors:  William T Carpenter; Jason Schiffman
Journal:  Schizophr Bull       Date:  2015-07-10       Impact factor: 9.306

4.  Diagnostic Categories: Provisional, Not Otherwise Classified, or Place-holder?

Authors:  William T Carpenter; Darrel Regier
Journal:  Schizophr Bull       Date:  2016-08-27       Impact factor: 9.306

5.  A Severity-Based Clinical Staging Model for the Psychosis Prodrome: Longitudinal Findings From the New York Recognition and Prevention Program.

Authors:  Ricardo E Carrión; Christoph U Correll; Andrea M Auther; Barbara A Cornblatt
Journal:  Schizophr Bull       Date:  2017-01       Impact factor: 9.306

6.  Attenuated psychosis syndrome: benefits of explicit recognition.

Authors:  Jason Schiffman; William T Carpenter
Journal:  Shanghai Arch Psychiatry       Date:  2015-02-25

7.  Progressive Decline in Hippocampal CA1 Volume in Individuals at Ultra-High-Risk for Psychosis Who Do Not Remit: Findings from the Longitudinal Youth at Risk Study.

Authors:  New Fei Ho; Daphne J Holt; Mike Cheung; Juan Eugenio Iglesias; Alex Goh; Mingyuan Wang; Joseph Kw Lim; Joshua de Souza; Joann S Poh; Yuen Mei See; Alison R Adcock; Stephen J Wood; Michael Wl Chee; Jimmy Lee; Juan Zhou
Journal:  Neuropsychopharmacology       Date:  2017-01-12       Impact factor: 7.853

8.  Clinical high-risk criteria of psychosis in 8-17-year-old community subjects and inpatients not suspected of developing psychosis.

Authors:  Frauke Schultze-Lutter; Petra Walger; Maurizia Franscini; Nina Traber-Walker; Naweed Osman; Helene Walger; Benno G Schimmelmann; Rahel Flückiger; Chantal Michel
Journal:  World J Psychiatry       Date:  2022-03-19

9.  Values and DSM-5: looking at the debate on attenuated psychosis syndrome.

Authors:  Arthur Maciel Nunes Gonçalves; Clarissa de Rosalmeida Dantas; Claudio E M Banzato
Journal:  BMC Med Ethics       Date:  2016-01-20       Impact factor: 2.652

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.